Frank Hester, CEO of the company, said that the AI can identify ovarian cancer in more than 50 percent of cases up to two years before a physician based on patients’ medical records. He is lending his technology to physicians and nurses throughout the U.K.
TPP has a partnership with the U.K.’s National Health Services. Per the agreement, the technology company has access to more than 50 million patient records. With the data, TPP has been able to develop AI programs to help physicians.
More articles on AI:
Microsoft AI, research head steps down
Healthcare leaders debunk 3 myths about machine learning
Baystate Health to develop AI tools that match patients to clinical trials
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
